En las últimas dos décadas, una disciplina científica ha iluminado —literalmente— el estudio del cerebro y de las células: la optogenética. Este campo emergente combina la genética y la óptica para controlar la actividad de neuronas y otro …
Optogenética: cómo la luz está revolucionando la neurociencia y la medicina del futuro Read More »
En los áridos paisajes de Namibia, como surcos dibujados por una mano invisible, brotan miles de parches circulares carentes de vegetación, rodeados por anillos de hierba. Durante décadas, estos fenómenos han sido conocidos como “círculos fantasma” o &l …
Lazzaro Spallanzani (1729–1799) fue un sacerdote, naturalista y biólogo italiano cuyas investigaciones revolucionaron la comprensión de la vida y sentaron las bases de la microbiología y la fisiología experimental. Su incansable curiosidad, rigor científico y …
Las computadoras cuánticas son ordenadores con la capacidad de realizar algunos tipos importantes de cálculos a una velocidad muchísimo mayor que la alcanzable por la más potente de las supercomputadoras convencionales. Pero, por ahora, los componentes básicos que …
BioSpace has named 50 life sciences companies to its 2026 Best Places to Work list. AbbVie, Amneal Pharmaceuticals and BridgeBio executives share what makes their organizations special.
BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces Read More »
Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for domestic drug manufacturing.
Generic Drug and API Manufacturers Call for Onshoring Incentives Read More »
Had Pfizer’s Freda Lewis-Hall not stepped in, SpringWorks’ rare disease treatment may never have reached patients. Pharmas can act now to help find the next Gomekli.
Pharma Is Sitting on Hidden Cures. Find Your “Freda” To Unlock Them Read More »
More than 30 organizations, including AdvaMed and the American Clinical Laboratory Association, are pushing for a permanent legislative solution to stop looming Medicare payment cuts for diagnostic tests.
Health groups urge passage of bill to ease Medicare pay cuts for tests Read More »
The CMS finalized the Medicare physician fee schedule for 2026 on Friday, one day before the statutory deadline. It includes an overall payment hike and a few policies that are deeply unpopular with specialists.
Medicare finalizes controversial cut to specialty care next year Read More »
At the center of the licensing deal is an NLRP3 inhibitor that has shown “encouraging efficacy in acute inflammation models,” according to TransThera, indicating its potential in various metabolic and inflammatory diseases.
Neurocrine Goes to China To Grow Pipeline in up to $881M TransThera Deal Read More »
